Horizon Funds - Horizon Flexible Income ETF
US ˙ BATS ˙ US33938J1060

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Samuel D Colella. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Samuel D Colella har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:FLXN / Horizon Funds - Horizon Flexible Income ETF Director 0
US:FLDM / Standard BioTools Inc Director 161.109
US:GKOS / Glaukos Corporation 496
US:PZRX / PhaseRx, Inc. 10% Owner 1.931.094
US:INGN / Inogen, Inc. 10% Owner 55.345
US:EYES / Vivani Medical Inc 10% Owner 4.370.964
US:GHDX / Genomic Health, Inc. Director 5.305
US:VCYT / Veracyte, Inc. Director, 10% Owner 10.000
US:JAZZ / Jazz Pharmaceuticals plc Director 0
US:PODD / Insulet Corporation 0
Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Samuel D Colella. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb FLXN / Horizon Funds - Horizon Flexible Income ETF – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-08-08 FLXN COLELLA SAMUEL D 2.000 10,7400 2.000 10,7400 21.480 154 21.1300 20.780 96,74
2017-06-05 FLXN COLELLA SAMUEL D 5.000 17,0095 5.000 17,0095 85.048
2016-12-01 FLXN COLELLA SAMUEL D 10.000 16,3807 10.000 16,3807 163.807
2016-11-21 FLXN COLELLA SAMUEL D 33.333 18,0000 33.333 18,0000 599.994
2016-06-21 FLXN COLELLA SAMUEL D 13.222 13,6223 13.222 13,6223 180.114
2016-06-21 FLXN COLELLA SAMUEL D 4.600 13,7583 4.600 13,7583 63.288
2016-06-21 FLXN COLELLA SAMUEL D 504 13,6523 504 13,6523 6.881
2016-06-21 FLXN COLELLA SAMUEL D 400 13,7078 400 13,7078 5.483
2016-06-20 FLXN COLELLA SAMUEL D 3.435 13,9796 3.435 13,9796 48.020
2016-06-20 FLXN COLELLA SAMUEL D 3.343 13,7043 3.343 13,7043 45.813
2016-06-08 FLXN Versant Ventures III, LLC 710.091 14,0000 710.091 14,0000 9.941.274
2016-06-08 FLXN Versant Ventures III, LLC 4.194 14,0000 4.194 14,0000 58.716
2014-02-18 FLXN COLELLA SAMUEL D 307.692 13,0000 307.692 13,0000 3.999.996

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Insidersalg FLXN / Horizon Funds - Horizon Flexible Income ETF – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Insiderkøb GKOS / Glaukos Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GKOS / Glaukos Corporation Insider Trades
Insidersalg GKOS / Glaukos Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2016-05-31 GKOS VERSANT VENTURES I LLC 10.970 23,9800 10.970 23,9800 263.061 1 24.3200 3.730 1,42
2016-05-31 GKOS VERSANT VENTURES I LLC 23.088 23,9800 23.088 23,9800 553.650

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GKOS / Glaukos Corporation Insider Trades
Insiderkøb INGN / Inogen, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INGN / Inogen, Inc. Insider Trades
Insidersalg INGN / Inogen, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2014-11-17 INGN Versant Ventures II LLC 5.343 24,8852 5.343 24,8852 132.962 15 23.9200 -5.156 -3,88
2014-11-14 INGN Versant Ventures II LLC 3.928 25,0627 3.928 25,0627 98.446
2014-11-13 INGN Versant Ventures II LLC 5.505 25,1814 5.505 25,1814 138.624
2014-11-10 INGN Versant Ventures II LLC 2.992 24,4201 2.992 24,4201 73.065
2014-10-24 INGN Versant Ventures II LLC 4.647 20,7565 4.647 20,7565 96.455
2014-10-09 INGN Versant Ventures II LLC 1.756 20,8255 1.756 20,8255 36.570
2014-10-09 INGN Versant Ventures II LLC 144 20,8255 144 20,8255 2.999
2014-10-08 INGN Versant Ventures II LLC 6.382 21,0266 6.382 21,0266 134.192
2014-10-08 INGN Versant Ventures II LLC 525 21,0266 525 21,0266 11.039
2014-09-09 INGN Versant Ventures II LLC 7.388 23,2496 7.388 23,2496 171.768

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INGN / Inogen, Inc. Insider Trades
Insiderkøb VANI / Vivani Medical, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VANI / Vivani Medical, Inc. Insider Trades
Insidersalg VANI / Vivani Medical, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VANI / Vivani Medical, Inc. Insider Trades
Insiderkøb VCYT / Veracyte, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VCYT / Veracyte, Inc. Insider Trades
Insidersalg VCYT / Veracyte, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VCYT / Veracyte, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Samuel D Colella som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -7.000 0 -100,00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -7.000 0 -100,00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -12.500 0 -100,00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -12.500 0 -100,00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -12.500 0 -100,00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -12.500 0 -100,00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -9.000 0 -100,00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
D - Sale to Issuer -9.000 0 -100,00
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -250 0 -100,00 8,50 -2.125
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -19.653 0 -100,00 8,50 -167.050
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -943 0 -100,00 8,50 -8.016
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -388.683 0 -100,00 8,50 -3.303.806
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -5.871 0 -100,00 8,50 -49.904
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -994.129 0 -100,00 8,50 -8.450.096
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -5.000 0 -100,00 8,50 -42.500
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -72.035 0 -100,00 8,50 -612.298
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -1.000 0 -100,00 8,50 -8.500
2021-11-19 2021-11-19 4 FLXN Flexion Therapeutics Inc
Common Stock
D - Sale to Issuer -9.000 0 -100,00 8,50 -76.500
2021-06-28 2021-06-24 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 7.000 7.000
2021-06-28 2021-06-24 4 FLXN Flexion Therapeutics Inc
Common Stock
A - Award 4.500 11.198 67,18
2021-03-12 2021-01-15 4/A FLXN Flexion Therapeutics Inc
Common Stock
J - Other 2.198 69.837 3,25
2021-01-20 2021-01-15 4 FLXN Flexion Therapeutics Inc
Common Stock
J - Other 943 943
2021-01-20 2021-01-15 4 FLXN Flexion Therapeutics Inc
Common Stock
J - Other 2.198 47.531 4,85
2021-01-20 2021-01-15 4 FLXN Flexion Therapeutics Inc
Common Stock
J - Other -14.868 5.871 -71,69
2021-01-20 2021-01-15 4 FLXN Flexion Therapeutics Inc
Common Stock
J - Other 19.653 19.653
2021-01-20 2021-01-15 4 FLXN Flexion Therapeutics Inc
Common Stock
J - Other -648.266 0 -100,00
2021-01-20 2021-01-15 4 FLXN Flexion Therapeutics Inc
Common Stock
J - Other 648.266 648.266
2021-01-20 2021-01-15 4 FLXN Flexion Therapeutics Inc
Common Stock
J - Other -2.517.541 994.129 -71,69
2020-06-12 2020-06-10 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 7.000 7.000
2020-06-12 2020-06-10 4 FLXN Flexion Therapeutics Inc
Common Stock
A - Award 4.500 30.004 17,64
2020-03-12 2020-03-11 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 10.000 161.109 6,62 2,65 26.545 427.664
2020-03-12 2020-03-10 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 10.000 151.109 7,09 2,77 27.738 419.146
2020-02-06 2020-02-04 4 FLDM FLUIDIGM CORP
Common Stock
A - Award 21.628 141.109 18,10
2019-08-28 2019-08-27 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 2.000 119.481 1,70 5,19 10.372 619.617
2019-08-12 2019-08-08 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 1.000 117.481 0,86 6,65 6.653 781.636
2019-08-09 2019-08-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 2.000 45.333 4,62 10,74 21.480 486.876
2019-08-08 2019-08-07 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 1.000 116.481 0,87 6,86 6.857 798.675
2019-08-08 2019-08-06 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 8.000 115.481 7,44 7,02 56.183 811.012
2019-06-24 2019-06-20 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
M - Exercise -10.600 0 -100,00 5,57 -59.042
2019-06-24 2019-06-20 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
M - Exercise -5.000 0 -100,00 3,43 -17.150
2019-06-24 2019-06-20 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
M - Exercise -3.000 0 -100,00 5,44 -16.320
2019-06-24 2019-06-20 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
M - Exercise -5.000 0 -100,00 10,45 -52.250
2019-06-24 2019-06-20 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 10.600 107.481 10,94 5,57 59.042 598.669
2019-06-24 2019-06-20 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 5.000 96.881 5,44 3,43 17.150 332.302
2019-06-24 2019-06-20 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 3.000 91.881 3,38 5,44 16.320 499.833
2019-06-24 2019-06-20 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 5.000 88.881 5,96 10,45 52.250 928.806
2019-06-21 2019-06-19 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 12.500 12.500
2019-06-05 2019-06-03 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
A - Award 6.796 6.796
2019-06-05 2019-06-03 4 FLDM FLUIDIGM CORP
Common Stock
A - Award 3.987 99.758 4,16
2019-02-14 2019-02-12 4 FLDM FLUIDIGM CORP
Common Stock
A - Award 9.748 95.771 11,33
2018-06-21 2018-06-20 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 12.500 12.500
2018-06-01 2018-05-31 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
A - Award 10.600 10.600
2018-06-01 2018-05-31 4 FLDM FLUIDIGM CORP
Common Stock
A - Award 6.100 86.023 7,63
2018-06-01 2018-05-30 4 FLDM FLUIDIGM CORP
Restricted Stock Units
M - Exercise -3.000 0 -100,00
2018-06-01 2018-05-30 4 FLDM FLUIDIGM CORP
Restricted Stock Units
M - Exercise -5.000 0 -100,00
2018-06-01 2018-05-30 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 3.000 79.923 3,90
2018-06-01 2018-05-30 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 5.000 76.923 6,95
2018-02-15 2018-02-13 4 FLDM FLUIDIGM CORP
Common Stock
A - Award 12.830 71.923 21,71
2018-01-03 2017-12-31 4 FLDM FLUIDIGM CORP
Restricted Stock Units
M - Exercise -7.848 0 -100,00
2018-01-03 2017-12-31 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 7.848 59.093 15,31
2018-01-03 2017-12-28 4 FLDM FLUIDIGM CORP
Common Stock
G - Gift -1.800 51.245 -3,39
2017-10-02 2017-09-30 4 FLDM FLUIDIGM CORP
Restricted Stock Units
M - Exercise -7.848 7.848 -50,00
2017-10-02 2017-09-30 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 7.848 53.045 17,36
2017-09-14 2017-09-13 4 FLDM FLUIDIGM CORP
Restricted Stock Units
A - Award 3.000 3.000
2017-09-14 2017-09-13 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
A - Award 3.000 3.000
2017-08-10 2017-08-08 4 FLDM FLUIDIGM CORP
Restricted Stock Units
A - Award 15.696 15.696
2017-08-08 2017-08-08 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 35.895 53.395 205,11 2,77 99.357 147.797
2017-08-02 2017-08-01 4 FLDM FLUIDIGM CORP
Restricted Stock Units
A - Award 5.000 5.000
2017-08-02 2017-08-01 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
A - Award 5.000 5.000
2017-08-02 2017-07-31 4 FLDM FLUIDIGM CORP
Restricted Stock Units
M - Exercise -5.000 0 -100,00
2017-08-02 2017-07-31 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 5.000 45.197 12,44
2017-07-27 2017-06-22 4 FLXN Flexion Therapeutics Inc
Stock Option (Right to Buy)
A - Award 12.500 12.500
2017-06-06 2017-06-05 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 5.000 5.000 17,01 85.048 85.048
2017-05-26 2017-05-24 4 FLDM FLUIDIGM CORP
Common Stock
W - Other 3.326 3.326
2017-05-26 2017-05-24 4 FLDM FLUIDIGM CORP
Common Stock
W - Other -3.326 40.197 -7,64
2017-05-11 2017-05-09 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 7.500 17.500 75,00 5,92 44.438 103.688
2017-03-15 2017-03-14 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 10.000 10.000 5,00 49.973 49.973
2016-12-21 2016-12-20 4 FLDM FLUIDIGM CORP
Common Stock
G - Gift -600 43.523 -1,36
2016-12-14 2016-12-14 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 5.000 44.123 12,78 7,39 36.935 325.937
2016-12-05 2016-12-01 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 10.000 43.333 30,00 16,38 163.807 709.825
2016-12-02 2016-11-30 4 FLDM FLUIDIGM CORP
Common Stock
P - Purchase 20.000 39.123 104,59 6,32 126.470 247.394
2016-12-02 2016-03-15 4 FLDM FLUIDIGM CORP
Common Stock
G - Gift -550 19.123 -2,80
2016-11-22 2016-11-21 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 33.333 33.333 18,00 599.994 599.994
2016-08-04 2016-08-03 4 FLDM FLUIDIGM CORP
Restricted Stock Units
A - Award 5.000 5.000
2016-08-04 2016-08-03 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
A - Award 5.000 5.000
2016-06-22 2016-06-21 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 400 25.504 1,59 13,71 5.483 349.604
2016-06-22 2016-06-21 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 504 25.104 2,05 13,65 6.881 342.727
2016-06-22 2016-06-21 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 4.600 24.600 23,00 13,76 63.288 338.454
2016-06-22 2016-06-21 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 13.222 20.000 195,07 13,62 180.114 272.446
2016-06-22 2016-06-20 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 3.343 6.778 97,32 13,70 45.813 92.888
2016-06-22 2016-06-20 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 3.435 3.435 13,98 48.020 48.020
2016-06-22 2016-06-10 4/A FLXN Flexion Therapeutics Inc
Stock Option (Right to Buy)
A - Award 12.500 12.500
2016-06-13 2016-06-10 4 FLXN Flexion Therapeutics Inc
Stock Option (Right to Buy)
A - Award 12.500 12.500
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 4.194 20.739 25,35 14,00 58.716 290.346
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 710.091 3.511.670 25,35 14,00 9.941.274 49.163.380
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 4.194 20.739 25,35 14,00 58.716 290.346
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 710.091 3.511.670 25,35 14,00 9.941.274 49.163.380
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 496 496
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 2.317 2.317
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 397 397
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 397 397
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 989 989
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 989 989
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 741 741
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 128.758 128.758
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
S - Sale -23.088 109.395 -17,43 23,98 -553.650 2.623.292
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
S - Sale -10.970 51.247 -17,63 23,98 -263.061 1.228.903
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other -9.892 46.804 -17,45
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other -505.297 2.379.539 -17,52
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
P - Purchase 596.477 1.931.094 44,69 5,00 2.982.385 9.655.470
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -182.914 1.334.617 -12,05 0,01 -1.829 13.346
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -73.615 1.517.531 -4,63 0,01 -736 15.175
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
P - Purchase 3.523 11.408 44,68 5,00 17.615 57.040
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -1.080 7.885 -12,05 0,01 -11 79
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -435 8.965 -4,63 0,01 -4 90
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2015-07-31 2015-07-29 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
A - Award 10.000 10.000
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -552 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -1.296 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -577 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -27.612 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -5.465 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -12.840 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -5.715 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -273.337 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -3.271 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -7.684 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -3.420 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -163.592 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -10.791 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -25.226 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -11.805 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -548.464 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -9.386 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -21.900 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -10.428 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -479.714 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -16.666 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -38.888 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -18.518 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -851.852 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -10.800 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -25.200 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -12.000 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -552.000 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -235 56.696 -0,41 18,00 -4.230 1.020.528
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 552 56.931 0,98
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 56.379 56.379
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -551 132.483 -0,41 18,00 -9.918 2.384.694
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 1.296 133.034 0,98
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 131.738 131.738
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -246 62.217 -0,39 18,00 -4.428 1.119.906
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 577 62.463 0,93
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 61.886 61.886
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -11.736 2.884.835 -0,41 18,00 -211.248 51.927.030
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 27.612 2.896.571 0,96
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 2.868.959 2.868.959
2015-06-19 2015-06-17 4 FLXN Flexion Therapeutics Inc
Stock Option (Right to Buy)
A - Award 9.000 9.000
2015-05-11 2014-11-07 4/A INGN Inogen Inc
Common Stock
S - Sale -3.150 55.345 -5,39 23,95 -75.442 1.325.507
2015-05-11 2014-11-06 4/A INGN Inogen Inc
Common Stock
S - Sale -4.238 58.495 -6,76 24,56 -104.092 1.436.737
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 1.398 4.572 44,05
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 486 3.174 18,08
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.595 14.889 60,20
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 243 9.294 2,68
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.595 14.889 60,20
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 243 9.294 2,68
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.596 15.180 58,39
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 388 9.584 4,22
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.594 14.789 60,84
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 194 9.195 2,16
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -42.216 0 -100,00
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 42.216 42.216
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -389.136 2.917.544 -11,77
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -3.476 26.061 -11,77
2015-02-23 2015-02-20 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
M - Exercise -5.700 0 -100,00
2015-02-23 2015-02-20 4 FLDM FLUIDIGM CORP
Common Stock
S - Sale -5.700 19.673 -22,46 38,92 -221.849 765.689
2015-02-23 2015-02-20 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 5.700 25.373 28,97 4,45 25.343 112.811
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
M - Exercise -2.970 5.700 -34,26
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
M - Exercise -8.670 0 -100,00
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
M - Exercise -12.000 0 -100,00
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
M - Exercise -12.000 0 -100,00
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
M - Exercise -3.200 0 -100,00
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Common Stock
S - Sale -38.840 19.673 -66,38 38,97 -1.513.727 766.724
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 2.970 58.513 5,35 4,45 13.205 260.155
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 8.670 55.543 18,50 8,37 72.596 465.073
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 12.000 46.873 34,41 13,08 156.960 613.099
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 12.000 34.873 52,46 14,00 168.000 488.222
2015-02-23 2015-02-19 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 3.200 22.873 16,27 16,00 51.200 365.968
2015-02-20 2015-02-18 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
M - Exercise -8.800 3.200 -73,33
2015-02-20 2015-02-18 4 FLDM FLUIDIGM CORP
Common Stock
S - Sale -8.800 19.673 -30,91 38,71 -340.659 761.565
2015-02-20 2015-02-18 4 FLDM FLUIDIGM CORP
Common Stock
M - Exercise 8.800 28.473 44,73 16,00 140.800 455.568
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 4.459 16.329 37,57
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 56.385 46,25
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 87.719 25,52
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 87.461 25,61
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 85.497 26,35
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other -136.039 0 -100,00
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 972 17.301 5,95
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 486 56.871 0,86
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 486 88.205 0,55
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 389 56.516 0,69
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 778 54.941 1,44
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 136.039 136.039
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -778.272 1.263.716 -38,11
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -6.952 7.812 -47,09
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 607 11.870 5,39
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 1.986 11.263 21,41
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 244 38.295 0,64
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.942 38.051 26,38
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 488 36.331 1,36
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.950 35.843 28,50
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 607 11.870 5,39
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 1.986 11.263 21,41
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 244 38.295 0,64
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.942 38.051 26,38
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 488 36.331 1,36
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.950 35.843 28,50
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.370.964
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
82.949
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
39.062
2014-11-19 2014-11-17 4 INGN Inogen Inc
Common Stock
S - Sale -5.343 40.569 -11,64 24,89 -132.962 1.009.568
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-14 2014-11-14 4 INGN Inogen Inc
Common Stock
S - Sale -3.928 45.912 -7,88 25,06 -98.446 1.150.679
2014-11-14 2014-11-13 4 INGN Inogen Inc
Common Stock
S - Sale -5.505 49.840 -9,95 25,18 -138.624 1.255.041
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 972 9.277 11,70
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 3.733 8.305 81,65
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 486 30.304 1,63
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 486 30.304 1,63
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 29.818 100,27
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 29.818 100,27
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 29.818 100,27
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 388 30.109 1,31
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.932 29.721 100,97
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 776 27.893 2,86
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -113.112 0 -100,00
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 113.112 113.112
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -778.272 2.528.408 -23,54
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -6.952 19.109 -26,68
2014-11-12 2014-11-10 4 INGN Inogen Inc
Common Stock
S - Sale -2.992 12.188 -19,71 24,42 -73.065 297.632
2014-11-07 2014-11-07 4 INGN Inogen Inc
Common Stock
S - Sale -3.150 55.345 -5,39 23,95 -75.442 1.325.507
2014-11-07 2014-11-06 4 INGN Inogen Inc
Common Stock
S - Sale -4.238 58.495 -6,76 24,56 -104.092 1.436.737
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 1.398 4.572 44,05
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 486 3.174 18,08
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.595 14.889 60,20
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 243 9.294 2,68
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.595 3.321.569 0,17
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 243 3.315.974 0,01
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.596 15.180 58,39
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 388 9.584 4,22
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.594 14.789 60,84
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 194 9.195 2,16
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other -3.476 26.061 -11,77
2014-10-28 2014-10-24 4 INGN Inogen Inc
Common Stock
S - Sale -4.647 0 -100,00 20,76 -96.455
2014-10-14 2014-10-09 4 INGN Inogen Inc
Common Stock
S - Sale -144 0 -100,00 20,83 -2.999
2014-10-14 2014-10-09 4 INGN Inogen Inc
Common Stock
S - Sale -1.756 0 -100,00 20,83 -36.570
2014-10-09 2014-10-08 4 INGN Inogen Inc
Common Stock
S - Sale -525 144 -78,48 21,03 -11.039 3.028
2014-10-09 2014-10-08 4 INGN Inogen Inc
Common Stock
S - Sale -6.382 1.756 -78,42 21,03 -134.192 36.923
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 669 669
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.138 8.138
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 2.202 2.688 453,09
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.808 9.051 3.624,69
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.808 9.051 3.624,69
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.808 3.408.001 0,26
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.807 9.001 4.539,69
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other -66.857 0 -100,00
2014-10-03 2014-10-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 350 5.305 7,06 28,54 9.989 151.405
2014-09-12 2014-09-10 4 FLXN Flexion Therapeutics Inc
Stock Option (right to buy)
X - Other -2.250 6.750 -25,00
2014-09-12 2014-09-10 4 FLXN Flexion Therapeutics Inc
Common Stock
X - Other 2.250 2.250 17,61 39.622 39.622
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 243 243
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 486 486
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 243 243
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 243 243
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 388 388
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 194 194
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other -389.136 3.306.680 -10,53
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other -3.476 29.537 -10,53
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
S - Sale -7.388 62.733 -10,54 23,25 -171.768 1.458.517
2014-07-03 2014-07-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 358 4.955 7,79 27,86 9.974 138.046
2014-06-10 2014-06-06 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
A - Award 10.000 10.000
2014-05-23 2014-05-21 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
A - Award 10.000 10.000
2014-05-21 2014-05-20 4 VCYT VERACYTE, INC.
Stock option (right to buy)
A - Award 10.000 10.000
2014-04-03 2014-04-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 376 4.597 8,91 26,57 9.990 122.142
2014-03-04 2014-03-03 4 FLXN Flexion Therapeutics Inc
Stock option (right to buy)
A - Award 9.000 9.000
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Series B Preferred Stock
C - Conversion -3.153.677 0 -100,00
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Series A Preferred Stock
C - Conversion -19.556.148 0 -100,00
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 307.692 3.206.807 10,61 13,00 3.999.996 41.688.491
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Common Stock
C - Conversion 387.906 2.899.115 15,45
2014-02-20 2014-02-18 4 FLXN Flexion Therapeutics Inc
Common Stock
C - Conversion 2.405.429 2.511.209 2.273,99
2014-02-11 3 FLXN Flexion Therapeutics Inc
Common Stock
211.560
2014-02-11 3 FLXN Flexion Therapeutics Inc
Common Stock
211.560
2014-01-03 2014-01-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 341 4.221 8,79 29,27 9.981 123.549
2013-11-08 2013-11-04 4/A FLDM FLUIDIGM CORP
Common Stock
J - Other 8.796 19.673 80,87
2013-11-08 2013-11-04 4/A FLDM FLUIDIGM CORP
Common Stock
J - Other 4.297 5.561 339,95
2013-11-05 2013-11-04 4 FLDM FLUIDIGM CORP
Common Stock
J - Other 8.063 18.940 74,13
2013-11-05 2013-11-04 4 FLDM FLUIDIGM CORP
Common Stock
J - Other 4.030 5.294 318,83
2013-11-05 2013-11-01 4 FLDM FLUIDIGM CORP
Common Stock
J - Other -34.585 0 -100,00
2013-11-05 2013-11-01 4 FLDM FLUIDIGM CORP
Common Stock
J - Other -11.797 0 -100,00
2013-11-05 2013-11-01 4 FLDM FLUIDIGM CORP
Common Stock
J - Other -13.345 0 -100,00
2013-11-05 2013-11-01 4 FLDM FLUIDIGM CORP
Common Stock
J - Other -640.900 0 -100,00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series C Convertible Preferred Stock
C - Conversion 18.880 0 -100,00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series C Convertible Preferred Stock
C - Conversion 3.196.673 0 -100,00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series B Convertible Preferred Stock
C - Conversion 23.580 0 -100,00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series B Convertible Preferred Stock
C - Conversion 3.992.420 0 -100,00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series A Convertible Preferred Stock
C - Conversion 42.469 0 -100,00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series A Convertible Preferred Stock
C - Conversion 7.190.864 0 -100,00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Common Stock
C - Conversion 21.232 21.232
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Common Stock
C - Conversion 3.594.989 3.594.989
2013-10-03 2013-10-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 329 3.880 9,26 30,33 9.979 117.680
2013-08-14 2013-08-14 4 FLDM FLUIDIGM CORP
Common Stock
S - Sale -10.655 34.585 -23,55 19,89 -211.933 687.913
2013-08-14 2013-08-14 4 FLDM FLUIDIGM CORP
Common Stock
S - Sale -3.634 11.797 -23,55 19,89 -72.282 234.648
2013-08-14 2013-08-13 4 FLDM FLUIDIGM CORP
Common Stock
J - Other 2.631 2.631
2013-08-14 2013-08-13 4 FLDM FLUIDIGM CORP
Common Stock
J - Other 1.264 1.264
2013-08-14 2013-08-13 4 FLDM FLUIDIGM CORP
Common Stock
S - Sale -6.638 45.240 -12,80 19,95 -132.425 902.520
2013-08-14 2013-08-13 4 FLDM FLUIDIGM CORP
Common Stock
S - Sale -2.265 15.431 -12,80 19,95 -45.186 307.842
2013-08-14 2013-08-12 4 FLDM FLUIDIGM CORP
Common Stock
J - Other -6.672 13.345 -33,33
2013-08-14 2013-08-12 4 FLDM FLUIDIGM CORP
Common Stock
J - Other -320.449 640.900 -33,33
2013-07-29 2013-07-25 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
A - Award 1.515 1.515
2013-07-03 2013-07-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 303 3.551 9,33 32,85 9.954 116.650
2013-06-11 2013-06-07 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
A - Award 8.250 8.250
2013-06-10 2013-06-06 4 FLDM FLUIDIGM CORP
Employee Stock Option (Right to Buy)
A - Award 12.000 12.000
2013-04-03 2013-04-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 357 3.248 12,35 27,99 9.992 90.912
2013-01-03 2013-01-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 367 2.891 14,54 27,24 9.997 78.751
2012-11-20 2012-11-20 4 GHDX GENOMIC HEALTH INC
Common Stock
S - Sale -3.629 0 -100,00 26,52 -96.232
2012-11-20 2012-11-20 4 GHDX GENOMIC HEALTH INC
Common Stock
S - Sale -1.871 0 -100,00 26,52 -49.614
2012-11-20 2012-11-19 4 GHDX GENOMIC HEALTH INC
Common Stock
S - Sale -16.573 3.629 -82,04 26,97 -447.043 97.889
2012-11-20 2012-11-19 4 GHDX GENOMIC HEALTH INC
Common Stock
S - Sale -8.543 1.871 -82,03 26,97 -230.441 50.469
2012-11-20 2012-11-16 4 GHDX GENOMIC HEALTH INC
Common Stock
J - Other 9.546 36.437 35,50
2012-11-20 2012-11-16 4 GHDX GENOMIC HEALTH INC
Common Stock
J - Other 4.689 17.911 35,46
2012-11-20 2012-11-16 4 GHDX GENOMIC HEALTH INC
Common Stock
J - Other -11.210 0 -100,00
2012-11-20 2012-11-16 4 GHDX GENOMIC HEALTH INC
Common Stock
J - Other -582.174 0 -100,00
2012-10-03 2012-10-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 288 2.524 12,88 35,89 10.336 90.586
2012-07-03 2012-07-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 299 2.236 15,44 33,40 9.987 74.682
2012-06-12 2012-06-08 4 GHDX GENOMIC HEALTH INC
Director Stock Option (right to buy)
A - Award 8.250 8.250
2012-05-18 2012-05-16 4 FLDM FLUIDIGM CORP
Stock Option (Right to Buy)
A - Award 12.000 12.000
2012-05-18 2012-05-18 4 GHDX GENOMIC HEALTH INC
Common Stock
S - Sale -6.137 20.202 -23,30 32,13 -197.168 649.046
2012-05-18 2012-05-18 4 GHDX GENOMIC HEALTH INC
Common Stock
S - Sale -3.163 10.414 -23,30 32,13 -101.620 334.579
2012-05-18 2012-05-17 4 GHDX GENOMIC HEALTH INC
Common Stock
S - Sale -11.213 26.339 -29,86 33,52 -375.888 882.949
2012-05-18 2012-05-17 4 GHDX GENOMIC HEALTH INC
Common Stock
S - Sale -5.781 13.577 -29,86 33,52 -193.794 455.135
2012-05-18 2012-05-16 4 GHDX GENOMIC HEALTH INC
Common Stock
J - Other 9.134 26.891 51,44
2012-05-18 2012-05-16 4 GHDX GENOMIC HEALTH INC
Common Stock
J - Other 4.496 13.222 51,52
2012-05-18 2012-05-16 4 GHDX GENOMIC HEALTH INC
Common Stock
J - Other -9.628 11.210 -46,20
2012-05-18 2012-05-16 4 GHDX GENOMIC HEALTH INC
Common Stock
J - Other -500.000 582.174 -46,20
2012-04-03 2012-04-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 326 1.937 20,24 30,61 9.979 59.292
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Option (right to buy)
M - Exercise -12.500 0 -100,00
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Option (right to buy)
M - Exercise -12.500 0 -100,00
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Option (right to buy)
M - Exercise -10.000 0 -100,00
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Option (right to buy)
M - Exercise -10.000 0 -100,00
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Option (right to buy)
M - Exercise -10.000 0 -100,00
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
F - Taxes -8.999 38.347 -19,01 48,60 -437.351 1.863.664
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
M - Exercise 12.500 47.346 35,87 34,99 437.375 1.656.637
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
F - Taxes -2.116 34.846 -5,72 48,60 -102.838 1.693.516
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
M - Exercise 12.500 36.962 51,10 8,23 102.875 304.197
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
F - Taxes -1.302 24.462 -5,05 48,60 -63.277 1.188.853
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 25.764 63,44 6,33 63.300 163.086
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
F - Taxes -1.613 15.764 -9,28 48,60 -78.392 766.130
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 17.377 135,56 7,84 78.400 136.236
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
F - Taxes -2.623 7.377 -26,23 48,60 -127.478 358.522
2012-01-13 2012-01-11 4 JAZZ JAZZ PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 10.000 12,75 127.500 127.500
2012-01-06 2012-01-01 4 GHDX GENOMIC HEALTH INC
Common Stock
A - Award 393 1.611 32,27 25,39 9.978 40.903
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series B Preferred Stock
C - Conversion -10.425 977.616 -1,06
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series E Preferred Stock
C - Conversion -2.092 988.041 -0,21
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series D Preferred Stock
C - Conversion -3.715 990.133 -0,37
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series C Preferred Stock
C - Conversion -13.442 993.848 -1,33
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series B Preferred Stock
C - Conversion -29.190 1.007.290 -2,82
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series E Preferred Stock
C - Conversion -5.185 1.036.480 -0,50
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series D Preferred Stock
C - Conversion -1.769 1.041.665 -0,17
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series C Preferred Stock
C - Conversion -6.401 1.043.434 -0,61
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series B Preferred Stock
C - Conversion -7.297 1.049.835 -0,69
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Series E Preferred Stock
C - Conversion -2.065 1.057.132 -0,19
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 10.425 81.581 14,65
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 2.092 71.156 3,03
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 3.715 69.064 5,68
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 13.442 65.349 25,90
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 29.190 51.907 128,49
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 5.185 22.717 29,57
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 1.769 17.532 11,22
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 6.401 15.763 68,37
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 7.297 9.362 353,37
2011-02-18 2011-02-15 4/A FLDM FLUIDIGM CORP
Common Stock
C - Conversion 2.065 2.065
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series E-1 Preferred Warrant (Right to Buy)
X - Other -8.257 0 -100,00
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series E-1 Preferred Stock
C - Conversion -7.596 8.257 -47,92
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series E-1 Preferred Stock
C - Conversion -148 15.853 -0,92
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series E-1 Preferred Stock
C - Conversion -346 16.001 -2,12
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series E-1 Preferred Stock
C - Conversion -164 16.347 -0,99
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series D Preferred Stock
C - Conversion -81.396 16.511 -83,14
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series C Preferred Stock
C - Conversion -294.457 97.907 -75,05
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series B Preferred Stock
C - Conversion -474.354 392.364 -54,73
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series E Preferred Stock
C - Conversion -103.546 866.718 -10,67
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series D Preferred Stock
C - Conversion -1.592 970.264 -0,16
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series C Preferred Stock
C - Conversion -5.760 971.856 -0,59
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
F - Taxes -11 1.059.186 0,00 13,50 -148 14.299.011
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
X - Other 8.247 1.059.197 0,78 0,02 165 21.184
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 7.596 1.050.940 0,73 0,02 152 21.019
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 148 1.043.344 0,01 0,02 3 20.867
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 346 1.043.196 0,03 0,02 7 20.864
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 164 1.042.850 0,02 0,02 3 20.857
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 81.396 1.042.686 8,47
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 294.457 961.290 44,16
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 474.354 666.833 246,44
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 103.546 192.479 116,43
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 1.592 88.933 1,82
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 5.760 87.341 7,06
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series B Preferred Stock
C - Conversion -10.425 977.616 -1,06
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series E Preferred Stock
C - Conversion -2.092 988.041 -0,21
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series D Preferred Stock
C - Conversion -3.715 990.133 -0,37
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series C Preferred Stock
C - Conversion -13.442 993.848 -1,33
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series B Preferred Stock
C - Conversion -29.190 1.007.290 -2,82
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series E Preferred Stock
C - Conversion -5.185 1.036.480 -0,50
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series D Preferred Stock
C - Conversion -1.769 1.041.665 -0,17
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series C Preferred Stock
C - Conversion -6.401 1.043.434 -0,61
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series B Preferred Stock
C - Conversion -7.297 1.049.835 -0,69
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Series E Preferred Stock
C - Conversion -2.065 1.057.132 -0,19
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 10.425 81.581 14,65
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 2.092 71.156 3,03
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 3.715 69.064 5,68
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 13.442 65.349 25,90
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 29.190 51.907 128,49
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 5.185 22.717 29,57
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 1.769 17.532 11,22
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 6.401 15.763 68,37
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 7.297 9.362 353,37
2011-02-17 2011-02-15 4 FLDM FLUIDIGM CORP
Common Stock
C - Conversion 2.065 2.065
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series E Preferred Stock
C - Conversion -11.538 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series E Preferred Stock
C - Conversion -5.495 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series E Preferred Stock
C - Conversion -252.748 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series E Preferred Stock
C - Conversion -4.945 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series D Preferred Stock
C - Conversion -58.085 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series D Preferred Stock
C - Conversion -27.660 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series D Preferred Stock
C - Conversion -1.272.337 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series D Preferred Stock
C - Conversion -24.894 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series C Preferred Stock
C - Conversion -80.000 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series C Preferred Stock
C - Conversion -38.095 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series C Preferred Stock
C - Conversion -1.752.381 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series C Preferred Stock
C - Conversion -34.286 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series B Preferred Stock
C - Conversion -85.135 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series B Preferred Stock
C - Conversion -40.541 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series B Preferred Stock
C - Conversion -1.864.865 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series B Preferred Stock
C - Conversion -36.486 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Common Stock
C - Conversion 89.372 89.372
2007-05-17 2007-05-14 4 PODD INSULET CORP
Common Stock
C - Conversion 42.557 42.557
2007-05-17 2007-05-14 4 PODD INSULET CORP
Common Stock
C - Conversion 1.957.713 1.957.713
2007-05-17 2007-05-14 4 PODD INSULET CORP
Common Stock
C - Conversion 38.301 38.301
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Series A Convertible Preferred Stock
C - Conversion -23.836 0 -100,00
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Series C Convertible Preferred Stock
C - Conversion -22.133 0 -100,00
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Series B Convertible Preferred Stock
C - Conversion -15.094 0 -100,00
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Series A Convertible Preferred Stock
C - Conversion -19.311 0 -100,00
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Series C Convertible Preferred Stock
C - Conversion -1.084.535 0 -100,00
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Series B Convertible Preferred Stock
C - Conversion -739.623 0 -100,00
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Series A Convertible Preferred Stock
C - Conversion -922.400 0 -100,00
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Common Stock
C - Conversion 23.836 23.836
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Common Stock
C - Conversion 56.538 56.538
2006-11-17 2006-11-15 4 THRM THERMAGE INC
Common Stock
C - Conversion 2.746.558 2.894.030 1.862,43
2006-11-17 2006-11-10 4/A THRM THERMAGE INC
Common Stock
P - Purchase 147.472 147.472 7,00 1.032.304 1.032.304
2006-11-14 2006-11-10 4 THRM THERMAGE INC
Common Stock
P - Purchase 150.000 150.000 7,00 1.050.000 1.050.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)